← SynDRA
CEFMENOXIME
SynDRA canonical compound SYN0023478 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | bacterial cell wall synthesis inhibitor |
|---|
| Indication | gram-negative bacterial infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
- Bact mrcA
- dacA
- dacB
- dacC
- ftsI
- mrcA
- mrcB
- mrdA
Mechanisms of action (all sources)
- bacterial cell wall synthesis inhibitor
- Bact mrcA BINDER
- mrcA INHIBITOR
- mrcB INHIBITOR
- dacC INHIBITOR
- mrdA INHIBITOR
- ftsI INHIBITOR
- dacA INHIBITOR
- dacB INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- PGR
- ADORA1
- HRH3
- HTR1A
- HTR2A
- HTR2B
- KCNH2
- MAOA
- MC3R
- MLNR
- NPY1R
- NR3C1
- ADORA2A
- OPRM1
- PDE3A
- PDE4D
- PPARG
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- HRH2
- HRH1
- GHSR
- ESR1
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
- BDKRB2
- CCKAR
- CCKBR
- CHRM1
- CHRM2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- S02A · ANTIINFECTIVES
- J01D · OTHER BETA-LACTAM ANTIBACTERIALS
Cross-references
Synonyms
- CEFMAX
- cefmenoxime hydrochloride
- cefmenoxime HCl
- Cefmenoxima
- SCE-1365
- Cefmax
- Cefmenoximum
- Tacef
- Cefmenoxime [INN]
- A 50912
- AB 50912
- SCE 1365
- Abbott-50192
- Cefmenoxima [INN-Spanish]
- Cefmenoxime (INN)
- Cefmenoximum [INN-Latin]
- KBZ4844CXN
- CHEBI:55490
- RefChem:574973
- DTXCID102755
- J01DA16
- SCE1365
- Bestron
- A-50912
- UNII-KBZ4844CXN
- CEFMENOXIME [MI]
- CEFMENOXIME [JAN]
- Epitope ID:120376
- CEFMENOXIME [WHO-DD]
- SCHEMBL152861
- orb1709222
- GTPL12024
- HY-B0875A
- GLXC-23140
- EBC-12395
- T1190L
- AKOS030573275
- NCGC00373220-03
Look up CEFMENOXIME in the interactive SynDRA portal →